» Articles » PMID: 29550447

Dynamic Changes in the Immunological Characteristics of T Lymphocytes in Surviving Patients with Severe Fever with Thrombocytopenia Syndrome (SFTS)

Overview
Publisher Elsevier
Date 2018 Mar 19
PMID 29550447
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high mortality. T cell deficiency has recently been described, but the changes in T cell functionality during acute SFTS virus (SFTSV) infection and the mechanisms leading to T lymphocyte death remain largely unknown. This study was conducted to evaluate T cell functionality and the expression of apoptotic/proliferation and activation/inhibition markers during acute SFTSV infection.

Methods: Twenty-eight surviving SFTS patients were sequentially sampled during their entire hospital stay. SFTSV RNA copies were investigated using real-time RT-PCR. The expression levels of apoptotic markers (annexin V and CD95) and proliferation and activation markers (Ki-67, HLA-DR, and CD25) and the expression levels of programmed cell death-1 (PD-1), interferon gamma (IFN-γ), and granzyme B in T cells were evaluated by flow cytometry for the SFTS patients.

Results: In parallel with T cell depletion, higher annexin V and CD95 expression was observed in SFTS patients. Additionally, the expression levels of Ki-67, HLA-DR, CD25, and PD-1 and the levels of IFN-γ and granzyme B in T lymphocytes were markedly increased in the SFTS patients.

Conclusions: T cell proliferation, activation, and functional enhancement were apparent despite the observation of T cell apoptosis, suggesting that these processes are involved in the complex protective response to SFTSV infection.

Citing Articles

Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study.

Xu N, Wen S, Yao Y, Guan Y, Zhao L, Yang L J Clin Microbiol. 2024; 63(1):e0128224.

PMID: 39688402 PMC: 11784442. DOI: 10.1128/jcm.01282-24.


Transcriptome Profiles Characteristics of the Peripheral Immune in Patients with Severe Fever with Thrombocytopenia Syndrome.

Zhang Y, Sun Q, Liu T, Chang C, Chen X, Duan Q J Inflamm Res. 2024; 17:8357-8374.

PMID: 39530000 PMC: 11552436. DOI: 10.2147/JIR.S485118.


Impact of Glucocorticoid Therapy on 28-Day Mortality in Patients Having Severe Fever with Thrombocytopenia Syndrome in an Intensive Care Unit: A Retrospective Analysis.

Wang G, Liu P, Xie H, Niu C, Lyu J, An Y J Inflamm Res. 2024; 17:7627-7637.

PMID: 39479263 PMC: 11521778. DOI: 10.2147/JIR.S478520.


TLR2/NF-кB signaling may control expansion and function of regulatory T cells in patients with severe fever with thrombocytopenia syndrome (SFTS).

Li M, Hu S, Xu L, Gao J, Zheng X, Li X Heliyon. 2024; 10(16):e35950.

PMID: 39224371 PMC: 11367551. DOI: 10.1016/j.heliyon.2024.e35950.


Antiviral immunity of severe fever with thrombocytopenia syndrome: current understanding and implications for clinical treatment.

Niu Y, Liu Y, Huang L, Liu W, Cheng Q, Liu T Front Immunol. 2024; 15:1348836.

PMID: 38646523 PMC: 11026560. DOI: 10.3389/fimmu.2024.1348836.